Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Mesenchymal stem cells and their secretome may offer a safe and effective treatment for systemic lupus erythematosus.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Lysophosphatidic acid boosts stem cell growth and movement by creating reactive oxygen species.

miRNAs in the Dlk1-Gtl2 region may improve lamb fur quality.

SQSTM1 is linked to increased risk of alopecia areata.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Spt4 and Spt6 are essential for fat cell development.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Tph cells are linked to the severity of systemic lupus erythematosus.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

LGR6+ stem cells may improve bone healing.